BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9815234)

  • 21. Relationship between beta-herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation.
    Chapenko S; Trociukas I; Donina S; Chistyakov M; Sultanova A; Gravelsina S; Lejniece S; Murovska M
    J Med Virol; 2012 Dec; 84(12):1953-60. PubMed ID: 23080502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infection by human herpesvirus type 6 (HHV-6) and renal transplantation].
    Merlino C; Sinesi F; Messina M; Giacchino F; Negro Ponzi A
    Minerva Urol Nefrol; 1992; 44(2):147-53. PubMed ID: 1329241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
    Schulz U; Solidoro P; Müller V; Szabo A; Gottlieb J; Wilkens H; Enseleit F
    Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S5-10. PubMed ID: 26900992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome.
    Rogers J; Rohal S; Carrigan DR; Kusne S; Knox KK; Gayowski T; Wagener MM; Fung JJ; Singh N
    Transplantation; 2000 Jun; 69(12):2566-73. PubMed ID: 10910278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.
    Snydman DR; Werner BG; Dougherty NN; Griffith J; Rubin RH; Dienstag JL; Rohrer RH; Freeman R; Jenkins R; Lewis WD; Hammer S; O'Rourke E; Grady GF; Fawaz K; Kaplan MM; Hoffman MA; Katz AT; Doran M;
    Ann Intern Med; 1993 Nov; 119(10):984-91. PubMed ID: 8214995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations.
    Van Leer-Buter CC; Sanders JS; Vroom HE; Riezebos-Brilman A; Niesters HG
    J Clin Virol; 2013 Oct; 58(2):422-6. PubMed ID: 23938304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies evaluating high-dose acyclovir, intravenous immune globulin, and cytomegalovirus hyperimmunoglobulin for prophylaxis against cytomegalovirus in kidney transplant recipients.
    Dickinson BI; Gora-Harper ML; McCraney SA; Gosland M
    Ann Pharmacother; 1996 Dec; 30(12):1452-64. PubMed ID: 8968459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.
    Fleming JN; Taber DJ; Weimert NA; Nadig S; McGillicuddy JW; Bratton CF; Baliga PK; Chavin KD
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28921781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation.
    Humar A; Kumar D; Raboud J; Caliendo AM; Moussa G; Levy G; Mazzulli T
    Am J Transplant; 2002 May; 2(5):461-6. PubMed ID: 12123213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection.
    Chou SW; Scott KM
    J Clin Microbiol; 1990 May; 28(5):851-4. PubMed ID: 2161867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of human herpesvirus-6, Epstein–Barr virus and cytomegalovirus infections in the etiopathogenesis of different types of cutaneous drug reactions.
    Ozcan D; Seçkin D; Bilezikçi B; Arslan H
    Int J Dermatol; 2010 Nov; 49(11):1250-4. PubMed ID: 21038542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
    Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevention of cytomegalovirus disease in renal transplantation.
    Davis CL
    Am J Kidney Dis; 1990 Sep; 16(3):175-88. PubMed ID: 1698020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antibody rises to cytomegalovirus and human herpesvirus type 6: frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses.
    Irving WL; Ratnamohan VM; Hueston LC; Chapman JR; Cunningham AL
    J Infect Dis; 1990 May; 161(5):910-6. PubMed ID: 2157772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal adult case of severe lymphocytopenia associated with reactivation of human herpesvirus 6.
    Yoshikawa T; Ihira M; Asano Y; Tomitaka A; Suzuki K; Matsunaga K; Kato Y; Hiramitsu S; Nagai T; Tanaka N; Kimura H; Nishiyama Y
    J Med Virol; 2002 Jan; 66(1):82-5. PubMed ID: 11748662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses.
    Ward KN; Gray JJ; Joslin ME; Sheldon MJ
    J Med Virol; 1993 Jan; 39(1):44-9. PubMed ID: 8380842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.